Doma perpetual capital management announces intent to nominate four highly qualified, independent director candidates at 2025 annual meeting of pacira biosciences, inc.

Expresses conviction in pacira's ip and belief that shares are significantly undervalued urges pacira to immediately commence stock tender offer with cash on hand miami , dec. 11, 2024 /prnewswire/ -- doma perpetual capital management llc (together with its affiliates, "doma"), which beneficially owns approximately 4.14% of the outstanding shares of common stock of pacira biosciences, inc. (nasdaq: pcrx) ("pacira" or the "company"), today announced that it intends to nominate four highly-qualified, independent director candidates at the company's 2025 annual meeting of stockholders, and stated that it has hired olshan frome wolosky llp as counsel to represent it in its dealings with the company. doma further stated that it believes strongly in the value of the company's intellectual property and that the company's stock is grossly undervalued and urged the company to immediately commence a stock tender offer for 10 million shares using its substantial cash on hand, and then execute its already-approved $150 million buyback program using the company's healthy and growing free cash flow.
DOMA Ratings Summary
DOMA Quant Ranking